Loading clinical trials...
Loading clinical trials...
Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of patients develop recurrent disease. Physical activity has emerged as a potential lifestyle intervention to red...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Abramson Cancer Center at Penn Medicine
NCT06746012 · Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8, and more
NCT04704661 · Advanced Breast Carcinoma, Advanced Colon Carcinoma, and more
NCT03516942 · Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8, and more
NCT05710406 · Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, and more
NCT04616183 · Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, and more
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions